UK - Oxford Capital Partners participates in £5m series-A funding for OrthoMimetics

Oxford Capital Partners has announced its investment in OrthoMimetics Limited, the first technology spin-out from the Cambridge-MIT Institute (CMI). Oxford Capital Partners joins a syndicate of investors including Schroders Investment Management Ltd, Sloane Robinson Private Equity and a global investment bank in a series-A funding round totalling ТЃ5m net of costs. The funding will enable the company to advance the first two products based on its technology platform, for cartilage and ligament repair respectively, towards market approval.